No Photo Available

Last Update

2017-02-27T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Renier Brentjens?

Dr. Renier J. Brentjens

Instructor In Medicine

Weill Cornell Medical College

HQ Phone: (212) 746-6464

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Weill Cornell Medical College

1300 York Avenue, Box 303

New York City, New York 10021

United States

Company Description

Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physician ... more

Find other employees at this company (4,380)

Background Information

Employment History

Imedex LLC

Weill Cornell Medical College

Consulting Editor

Journal of Clinical Investigation

Director of Cellular Therapeutics

MSKCC

Affiliations

Director, Cellular Therapeutics
Sloan-Kettering Cancer Center

Member of Laboratory
The Chemotherapy Foundation

Member of Laboratory
Sadelain

Education

MD

SUNY Buffalo

Web References (101 Total References)


Faculty | Lymphoma & Myeloma 2015

www.imedex.com [cached]

Renier J. Brentjens, MD, PhD Memorial Sloan-kettering Cancer Center Weill Cornell Medical College


Homepage der American Austrian Foundation

www.aaf-online.org [cached]

Renier J. Brentjens, MD, PhDInstructor, Leukemia ServiceDepartment of Medicine, MSKCCInstructor in Medicine, WCMC


Weill Cornell Department of Pharmacology

www.cornellpharmacology.org [cached]

Dr. Renier Brentjens


Weill Cornell Pharmacology Faculty, Pharmacology PhD Programs

www.cornellpharmacology.org [cached]

Not pictured: Dr. Renier Brentjens, Dr. Gabriela Chiosis, Dr. Diane Felsen, Dr. Hugh Hemmings, Dr. Timothy Hla, Dr. Francis Lee, Dr. Roberto Levi, Dr. Ari Melnick, Dr. Marcus Reidenberg, Dr. Neal Rosen, Dr. Steven Gross, Dr. Timothy Hla, Dr. Michael Kharas, Dr. Ingo Mellhinghoff, Dr. Arleen Rifkind, Dr. Miklos Toth

...
Dr. Renier Brentjens


Juno Therapeutics |

junotherapeutics.com [cached]

DR. RENIER BRENTJENS

...
DR. RENIER BRENTJENS
Scientific co-founder
Dr Brentjens obtained an MD/PhD (microbiology) from SUNY Buffalo, completed residency in medicine at Yale-New Haven Hospital, and a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC). Currently, Dr Brentjens is an associate member on the faculty at MSKCC and an attending physician on the Leukemia Service. As a medical oncology fellow at MSKCC, Dr Brentjens initiated the initial pre-clinical studies demonstrating the potential clinical application of autologous T cells genetically modified to target the CD19 antigen through the retroviral gene transfer of artificial T cell receptors termed chimeric antigen receptors (CARs). Following completion of his medical oncology training, Dr Brentjens became the principle investigator of his own laboratory. As a PI, Dr Brentjens successfully translated these studies to the clinical setting, treating patients with relapsed CD19+ tumors including chronic lymphocytic leukemia (CLL) and B cell acute lymphoblastic leukemia (B-ALL). Ongoing pre-clinical research in the laboratory is focused on the further development of CAR modified T cells designed to overcome the hostile immunosuppressive tumor microenvironment through the generation of "armored CAR T cells" currently being translated to the clinical setting as second generation CAR modified T cell clinical trials. Additionally, work in the Brentjens' lab has expanded this CAR technology to target additional tumor antigens.
More Info on Dr. Brentjens
...
Michel Sadelain and Renier J. Brentjens of Memorial Sloan Kettering Cancer Center, for winning the esteemed New York Intellectual Property Law Association (NYIPLA) "Inventor of the Year" award.
...
Sadelain and Brentjens were recognized for their extensive work in the design of chimeric antigen receptors (CARs).

Similar Profiles

Other People with this Name

Other people with the name Brentjens

Cas Brentjens
Infor Inc

Jan Brentjens
Saint Peter's Prep

Desiree Brentjens
Saudi Basic Industries Corporation

Joanneke Brentjens
freseniuskidneycare.com

Bart Brentjens
Bart Brentjens MTB Racing Team

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory